MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Theravance Biopharma Total Inventories 2011-2026 | TBPH
Annual Total Inventories Theravance Biopharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 16.8 M | 12.2 M | 10 M | 12.5 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.8 M | 10 M | 12.9 M |
Quarterly Total Inventories Theravance Biopharma
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.9 M | 17.9 M | 17.2 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 10 M | 10 M | 10 M | 10 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.9 M | 10 M | 13.1 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Harmony Biosciences Holdings
HRMY
|
5.36 M | $ 27.99 | 4.17 % | $ 1.59 B |  USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.81 | 1.31 % | $ 4.42 M |  China |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
Axsome Therapeutics
AXSM
|
27.9 M | $ 167.61 | -4.09 % | $ 8.34 B | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
2.17 B | $ 194.87 | -0.75 % | $ 28.5 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.23 B | $ 63.02 | 0.15 % | $ 12 B | USA |
 |
Baudax Bio
BXRX
|
5 M | - | 0.59 % | $ 63 K | USA |
 |
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.72 | 2.08 % | $ 4.55 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | USA |